The effects of tislelizumab treatment on the health-related quality of life of non-small cell lung cancer patients who progressed on a prior platinum-containing regimen.

Cai Zhou,Dingzhi Huang,Yiyuan Ma,Zhenyu Pan,Gisoo Barnes,Boxiong Tang

The effects of tislelizumab treatment on the health-related quality of life of non-small cell lung cancer patients who progressed on a prior platinum-containing regimen.

2021

Cai Zhou
Dingzhi Huang
Yiyuan Ma
Zhenyu Pan
Gisoo Barnes
Boxiong Tang

9069Background: Anti-PD-1/L1 therapies have improved overall survival (OS) by 2-4 months vs docetaxel in patients with advanced non−small cell lung cancer (NSCLC) who progressed after receiving a p...

Keywords:

Docetaxel
non small cell
Internal medicine
Medicine
Lung cancer
Regimen
health related quality of life
overall survival
Oncology
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations